Liviniti Announces Noom GLP-1 Companion and Comprehensive Weight Management Solution
Liviniti adopts Noom to support sustainable weight loss and healthier outcomes.Natchitoches, Louisiana--(Newsfile Corp. - January 9, 2024) - Liviniti, a...
Year: 2024
Halberd Corp. Signs Significant Revenue Sharing Agreement with Athena GTX
Athena will employ its successful history of securing government contracts, spearheading such initiativesJACKSON CENTER, PA / ACCESSWIRE / January 9,...
Levity Products, Inc Announces New Distribution Agreement with Domrex Pharma, Inc to Expand Market Reach
HUGO, MN / ACCESSWIRE / January 9, 2024 / Levity Products, Inc., an innovative provider of catheter stabilizers, today announced...
NEXGEL Subsidiary, CG Converting and Packaging, Begins 12,000 Square Foot Expansion of Texas Facility to Support the Expected Growth in Product Demand in 2024
LANGHORNE, Pa., Jan. 09, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: NXGL), a leading provider of...
SeaStar Medical Issued U.S. Patent with Broad Claims Covering Use of the Selective Cytopheretic Device for Multiple Clinical Indications
DENVER, Jan. 09, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a medical device company developing proprietary solutions...
SELLAS Life Sciences Receives FDA Fast Track Designation for SLS009 for Treatment of Relapsed/Refractory Acute Myeloid Leukemia and Provides Updated Data for Phase 2a Study of SLS009 in Relapsed/Refractory Acute Myeloid Leukemia Patients
- Phase 2a Enrollment Completed in 45 mg Safety Cohort: Median Overall Survival (OS) Not Reached; 89% of Patients Alive...
Dentsply Sirona to Present at J.P. Morgan Healthcare Conference, Provides Update on Anticipated Full Year 2023 Results
CHARLOTTE, N.C., Jan. 09, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) will present...
Branded Legacy, INC Successfully Closes Acquisition of All In Extracts, LLC
In a Move That Showcases the Power of Cooperation Over Competition, Companies Join Forces to Bring Exciting New Products to...
BioCorRx Appoints Renowned Investment and Capital Markets Executive Louis Lucido as President
ANAHEIM, CA, Jan. 09, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and...
IRADIMED CORPORATION Reports Unaudited Fourth Quarter and 2023 Revenue
Reports preliminary fourth quarter 2023 revenue of $17.5 million WINTER SPRINGS, Fla., Jan. 09, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION...
Ashley Black Interviewed Live from NYSE on Wellness Industry Innovations with FinTech TV
Ashley Black Interview from NYSE - ESG News Ashley Black Interview from NYSE - ESG News INTERVIEW HIGHLIGHTS $170 Million...
eFFECTOR Therapeutics to Host Virtual Investor R&D Day on January 24, 2024
- Summary of development progress for tomivosertib and zotatifin and a preview of anticipated 2024 milestones- - Review of recently...
Organovo To Present FXR314 IBD 3D Model Findings at Upcoming Crohn’s and Colitis Congress
SAN DIEGO, Jan. 09, 2024 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ: ONVO), a clinical stage biotechnology company that is...
Mainz Biomed Provides Year-End Corporate Review 2023
European Study ColoFuture and U.S. Study eAArly DETECT report sensitivity and specificity for the detection of Colorectal Cancer and Advanced...
Cardiol Therapeutics Announces it has Exceeded 50% Enrollment in its Phase II ARCHER Trial in Acute Myocarditis
Toronto, Ontario--(Newsfile Corp. - January 9, 2024) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a...
Skye Bioscience Receives IND Clearance for Phase 2 Clinical Trial of Nimacimab in Obesity and Chronic Kidney Disease
Phase 2 trial to assess impact of peripherally-acting CB1 inhibitor on weight loss and metabolic biomarkers related to co-morbid obesity...
Theralogix Launches Mannose One for Next-Level Urinary Tract Protection
ROCKVILLE, MD / ACCESSWIRE / January 8, 2024 / Theralogix, a national leader in the nutritional supplement industry, proudly announces...
Jovive Launches Two New Outpatient Wound Care Clinics in Southern California
Expanding Access to Specialized Wound CareEMERYVILLE, CA / ACCESSWIRE / January 8, 2024 / Jovive, a provider of patient-centric outpatient...
Mayo Clinic Platform and Techcyte Announce a Strategic Collaboration to Transform the Global Practice of Pathology
ROCHESTER, Minn. & OREM, Utah--(BUSINESS WIRE)--Mayo Clinic Platform, which enables global healthcare transformation through new technologies and a new approach...
Dror Ortho-Design, Inc. Files Three New Patents for its AI Based Smile Correction Solution
NEW YORK, NY / ACCESSWIRE / January 8, 2024 / Dror Ortho-Design, Inc. ("Dror" or the "Company") (OTC PINK:DROR), an...